Vismodegib

Brand name: Erivedge

Rank #446 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$17.4M

Total Cost

Share:

1,317

Total Claims

$17.4M

Total Cost

87

Prescribers

$13K

Cost per Claim

0

Beneficiaries

1,332

30-Day Fills

$200K

Avg Cost/Provider

15

Avg Claims/Provider

Share of Medicare Part D Spending

0.01%

of total Medicare Part D spending

$17.4M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $17.4M total

🔎 Data Overview

💰

At $13,243 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.

🔍

Average cost of $200,466 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of Vismodegib

#ProviderSpecialtyLocationClaimsCost
1Hildamari Justiniano GarciaDermatologyMayaguez, PR57$699K
2Phillip HallMicrographic Dermatologic SurgeryDayton, OH48$598K
3Robert GrahamHematology-OncologyChattanooga, TN28$413K
4Myron BednarHematologyFlemington, NJ24$361K
5Joseph UrashDermatologyShelby, NC24$351K
6Faith WhalenDermatologyBangor, ME17$308K
7Charles LoveDermatologyWest Des Moines, IA20$298K
8Kristopher KleinmanNurse PractitionerLas Vegas, NV18$274K
9Carlton PhillipsMicrographic Dermatologic SurgeryBirmingham, AL22$272K
10Nichol RaulersonPhysician AssistantSt Petersburg, FL23$270K
11David SemlerDermatologyPortage, MI21$268K
12Leslie PoinsetteDermatologyGreenville, SC18$259K
13Michael SharkeyDermatologyDublin, GA18$242K
14Melinda YushakHematology-OncologyNew Haven, CT16$242K
15Susannah FriemelInternal MedicineDavenport, IA16$237K

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

#DrugTotal CostClaims
443Encorafenib (Braftovi)$17.6M1,209
444Cladribine (Mavenclad)$17.5M228
445Enalapril Maleate (Enalapril Maleate)$17.5M673,317
446Vismodegib (Erivedge)$17.4M1,317
447Anastrozole (Anastrozole)$17.4M626,025
448Naproxen (Naproxen)$17.4M903,928
449Vedolizumab (Entyvio)$17.4M2,034

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology